![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 12, 8884-8891, March 23, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
, and
From the Epidermal growth factor (EGF) has been reported
to either sensitize or protect cells against ionizing radiation. We
report here that EGF increases radiosensitivity in both human
fibroblasts and lymphoblasts and down-regulates both ATM (mutated in
ataxia-telangiectasia (A-T)) and the catalytic subunit of
DNA-dependent protein kinase (DNA-PKcs). No further
radiosensitization was observed in A-T cells after pretreatment with
EGF. The down-regulation of ATM occurs at the transcriptional level.
Concomitant with the down-regulation of ATM, the DNA binding activity
of the transcription factor Sp1 decreased. A causal relationship was
established between these observations by demonstrating that
up-regulation of Sp1 DNA binding activity by granulocyte/macrophage
colony-stimulating factor rapidly reversed the EGF-induced decrease in
ATM protein and restored radiosensitivity to normal levels. Failure to
radiosensitize EGF-treated cells to the same extent as observed for A-T
cells can be explained by induction of ATM protein and kinase activity
with time post-irradiation. Although ionizing radiation damage to DNA
rapidly activates ATM kinase and cell cycle checkpoints, we have
provided evidence for the first time that alteration in the amount of
ATM protein occurs in response to both EGF and radiation exposure.
Taken together these data support complex control of ATM function that
has important repercussions for targeting ATM to improve
radiotherapeutic benefit.
Section for Radiobiology and Molecular
Environmental Research, Röntgenweg 11, 72076 Tübingen, Germany, the ¶ Queensland Cancer Fund
Research Laboratory, The Queensland Institute of Medical Research,
P. O. Royal Brisbane Hospital, Brisbane,
Queensland 4029, Australia, the
Gifu University School of
Medicine, 40 Tsukasa-Machi, Gifu 500-8076, Japan, and the
** Department of Surgery, University of Queensland, P. O. Royal
Brisbane Hospital, Brisbane, Queensland 4029, Australia

To whom correspondence should be addressed: the Queensland
Cancer Fund Research Laboratory, Queensland Institute of Medical Research, P. O. Royal Brisbane Hospital, Brisbane, Queensland 4029, Australia. Tel.: 61-7-33620341; Fax: 61-7-33620106; E-mail: martinL@qimr.edu.au.
This article has been cited by other articles:
![]() |
Y. Bu, Y. Suenaga, S. Ono, T. Koda, F. Song, A. Nakagawara, and T. Ozaki Sp1-mediated transcriptional regulation of NFBD1/MDC1 plays a critical role in DNA damage response pathway. Genes Cells, January 1, 2008; 13(1): 53 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Rudd, G. S. Sellick, E. L. Webb, D. Catovsky, and R. S. Houlston Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia Blood, July 15, 2006; 108(2): 638 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dittmann, C. Mayer, B. Fehrenbacher, M. Schaller, U. Raju, L. Milas, D. J. Chen, R. Kehlbach, and H. P. Rodemann Radiation-induced Epidermal Growth Factor Receptor Nuclear Import Is Linked to Activation of DNA-dependent Protein Kinase J. Biol. Chem., September 2, 2005; 280(35): 31182 - 31189. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Truman, N. Gueven, M. Lavin, S. Leibel, R. Kolesnick, Z. Fuks, and A. Haimovitz-Friedman Down-regulation of ATM Protein Sensitizes Human Prostate Cancer Cells to Radiation-induced Apoptosis J. Biol. Chem., June 17, 2005; 280(24): 23262 - 23272. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Peng, R. G. Woods, H. Beamish, R. Ye, S. P. Lees-Miller, M. F. Lavin, and J. S. Bedford Deficiency in the Catalytic Subunit of DNA-Dependent Protein Kinase Causes Down-Regulation of ATM Cancer Res., March 1, 2005; 65(5): 1670 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shahrabani-Gargir, T. K. Pandita, and H. Werner Ataxia-Telangiectasia Mutated Gene Controls Insulin-Like Growth Factor I Receptor Gene Expression in a Deoxyribonucleic Acid Damage Response Pathway via Mechanisms Involving Zinc-Finger Transcription Factors Sp1 and WT1 Endocrinology, December 1, 2004; 145(12): 5679 - 5687. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Starczynski, W. Simmons, J. R. Flavell, P. J. Byrd, G. S. Stewart, H. S. Kullar, A. Groom, J. Crocker, P. A.H. Moss, G. M. Reynolds, et al. Variations in ATM Protein Expression During Normal Lymphoid Differentiation and Among B-Cell-Derived Neoplasias Am. J. Pathol., August 1, 2003; 163(2): 423 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Silins, N. Finnberg, A. Stahl, J. Hogberg, and U. Stenius Reduced ATM kinase activity and an attenuated p53 response to DNA damage in carcinogen-induced preneoplastic hepatic lesions in the rat Carcinogenesis, December 1, 2001; 22(12): 2023 - 2031. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Kaufmann, C. I. Behe, V. M. Golubovskaya, L. L. Byrd, C. D. Albright, K. M. Borchet, S. C. Presnell, W. B. Coleman, J. W. Grisham, and G. J. Smith Aberrant cell cycle checkpoint function in transformed hepatocytes and WB-F344 hepatic epithelial stem-like cells Carcinogenesis, August 1, 2001; 22(8): 1257 - 1269. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |